Headquarters: Belfast, United Kingdom
Location ar ARVO: Booth 1248
MediNect Ophtho Bioservices is a new specialised preclinical contract research organisation founded as a spin-out company from Queen's University Belfast, where our experience was garnered. We have a dedicated focus on conducting in vivo studies of retinal diseases.
We work with pharmaceutical, biotech, and academia to help progress the development of therapeutics in:
- Age-related Macular Degeneration
- Diabetic Retinopathy
- Diabetic Macula Edema
- Retinitis Pigmentosa
- Retinopathy of Prematurity
- Retinal Vein Occlusion
We utilise high quality specialist ophthalmology equipment to deliver in depth analysis of your rodent efficacy studies.
Our passion is the quality of research we conduct and as such we work in a highly collaborative manner and utilise our close relationship with Queen's University Belfast to aid in MOA studies and ensure optimal study design for efficacy studies.
We always offer a customised study design to ensure you obtain the most out of your studies while aligning with future goals. We also offer non-GLP tolerabilty, toxicity, PK and PD ophthalmology studies.